Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Metan G et al. – Although severe underlying diseases play an important role in the clinical outcome of patients with Acb complex bacteraemia, carbapenem resistance and inappropriate therapy are of great concern. Special attention should be paid to infection control practices in the hospitals where MDR Acinetobacter infections are endemic, and well–controlled prospective clinical trials are needed to determine the optimal antimicrobial therapy in critically ill patients suspected of having MDR Acinetobacter bacteraemia.

Related Articles

In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore
The Journal of Antibiotics, 11/06/09    Relevance Score: 44%

Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland
BMJ - Archives of Diseases in Childhood, 10/29/09    Relevance Score: 44%

Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive bundle approach
American Journal of Infection Control, 11/10/09    Relevance Score: 42%

Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii
Journal of Clinical Microbiology, 11/02/09    Relevance Score: 42%

Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case—control study
The Lancet, 10/20/09    Relevance Score: 42%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address